Company Directory › Robotics › Complete Robots & Platforms › Medtronic (Hugo RAS) vs Mentee Robotics
Medtronic (Hugo RAS) vs Mentee Robotics
Medtronic (Hugo RAS) and Mentee Robotics are both complete robots & platforms companies. Their verified profiles differ on headquarters, country, industry focus, founding year and markets served. The table below sets out only those rows; everything else is on each company's own profile. Facts verified 6 November 2026.
Where they differ
| Company | Medtronic (Hugo RAS) | Mentee Robotics |
|---|---|---|
| Headquarters | Galway, Ireland | Herzliya, Israel |
| Country | Ireland | Israel |
| Industry | Surgical robotics — soft-tissue robotic-assisted surgery (Medtronic plc) | Complete robots — full-size AI humanoid robots |
| Founded | 2019 | 2022 |
| Markets served | Global; Hugo is commercially available across Europe, Latin America, Asia-Pacific and other regions, with the US launch under way following FDA clearance | Households, warehouses and manufacturing (company-stated target markets); development and pilots centred in Israel |
How Medtronic (Hugo RAS) and Mentee Robotics differ
One side is a surgical system inside a large medical technology group; the other is a young humanoid developer. Medtronic's Hugo robotic-assisted surgery system sits in the Surgical business of Medtronic plc, whose legal headquarters are in Galway, Ireland, with operational headquarters in Minneapolis, Minnesota. The Hugo system was unveiled in 2019, following a parent company founded in 1949; it received its European CE mark in 2021 and US FDA clearance for urologic procedures on 3 December 2025, commercially available across Europe, Latin America, Asia-Pacific and other regions, with the US launch under way. Medtronic plc is listed on the New York Stock Exchange, and Hugo is an internal business line rather than a separately funded entity. Mentee Robotics is headquartered in Herzliya, Israel, was founded in 2022, and builds full-size, AI-first humanoid robots designed to learn from human mentors; its company-stated target markets are households, warehouses and manufacturing, with pilots centred in Israel. It announced $17 million in Series A funding in 2024, and in January 2026 Mobileye announced it would acquire it for approximately $900 million. Neither record discloses headcount. A surgical team assessing soft-tissue robotic assistance reads the Hugo record; a buyer tracking general-purpose humanoids reads Mentee's.
Frequently asked questions
What is the main difference between Medtronic (Hugo RAS) and Mentee Robotics?
Medtronic (Hugo RAS) is based in Galway, Ireland and Mentee Robotics in Herzliya, Israel; they also differ on country, industry focus, founding year, markets served. The table above sets out both companies' entries row by row.
Are Medtronic (Hugo RAS) and Mentee Robotics in the same country?
No. Medtronic (Hugo RAS) is based in Galway, Ireland and Mentee Robotics in Herzliya, Israel.
Can one sourcing request reach both Medtronic (Hugo RAS) and Mentee Robotics?
Yes. Medtronic (Hugo RAS) can be reached through medtronic.com and Mentee Robotics through menteebot.com, or post one sourcing request and let both answer if they fit.
Does GlobleMatch rank Medtronic (Hugo RAS) above Mentee Robotics, or Mentee Robotics above Medtronic (Hugo RAS)?
Neither. There is no pay-to-rank and no paid placement in comparisons; order and content come from verified profile facts only.
Run Medtronic (Hugo RAS) or Mentee Robotics? Claim your free profile to keep your facts current.
Full profiles, with every fact and its source: Medtronic (Hugo RAS) and Mentee Robotics. Profile facts last verified: Medtronic (Hugo RAS) on 6 November 2026, Mentee Robotics on 6 November 2026.